Literature DB >> 12709027

Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection.

Grant R Yeaman1, Alexandra L Howell, Sally Weldon, Douglas J Demian, Jane E Collins, Denise M O'Connell, Susana N Asin, Charles R Wira, Michael W Fanger.   

Abstract

Human immunodeficiency virus-1 (HIV-1) is primarily a sexually transmitted disease. Identification of cell populations within the female reproductive tract that are initially infected, and the events involved in transmission of infection to other cells, remain to be established. In this report, we evaluated expression of HIV receptors and coreceptors on epithelial cells in the uterus and found they express several receptors critical for HIV infection including CD4, CXCR4, CCR5 and galactosylceramide (GalC). Moreover, expression of these receptors varied during the menstrual cycle. Expression of CD4 and CCR5 on uterine epithelial cells is high throughout the proliferative phase of the menstrual cycle when blood levels of oestradiol are high. In contrast, CXCR4 expression increased gradually throughout the proliferative phase. During the secretory phase of the cycle when both oestradiol and progesterone are elevated, CD4 and CCR5 expression decreased whereas CXCR4 expression remained elevated. Expression of GalC on endometrial glands is higher during the secretory phase than during the proliferative phase of the menstrual cycle. Because epithelial cells line the female reproductive tract and express HIV receptors and coreceptors, it is likely that they are one of the first cell types to become infected. The hormonal regulation of HIV receptor expression may affect a woman's susceptibility to HIV infection during her menstrual cycle. Moreover, selective coreceptor expression could account for the preferential transmission of R5-HIV-1 strains to women. In addition, these studies provide evidence that the uterus, and potentially the entire upper reproductive tract, are important sites for the initial events involved in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709027      PMCID: PMC1782948          DOI: 10.1046/j.1365-2567.2003.01623.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  51 in total

1.  Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner.

Authors:  M A Pedraza; J del Romero; F Roldán; S García; M C Ayerbe; A R Noriega; J Alcamí
Journal:  J Acquir Immune Defic Syndr       Date:  1999-06-01       Impact factor: 3.731

2.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

3.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

4.  CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause.

Authors:  H D White; K M Crassi; A L Givan; J E Stern; J L Gonzalez; V A Memoli; W R Green; C R Wira
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm.

Authors:  A Brogi; R Presentini; D Solazzo; P Piomboni; E Costantino-Ceccarini
Journal:  AIDS Res Hum Retroviruses       Date:  1996-04-10       Impact factor: 2.205

6.  Progestin regulation of interleukin-8 mRNA levels and protein synthesis in human endometrial stromal cells.

Authors:  A Arici; P C MacDonald; M L Casey
Journal:  J Steroid Biochem Mol Biol       Date:  1996-04       Impact factor: 4.292

7.  Progesterone implants enhance SIV vaginal transmission and early virus load.

Authors:  P A Marx; A I Spira; A Gettie; P J Dailey; R S Veazey; A A Lackner; C J Mahoney; C J Miller; L E Claypool; D D Ho; N J Alexander
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

8.  Progesterone control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition.

Authors:  R W Kelly; P Illingworth; G Baldie; R Leask; S Brouwer; A A Calder
Journal:  Hum Reprod       Date:  1994-02       Impact factor: 6.918

9.  Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.

Authors:  N Yahi; J M Sabatier; S Baghdiguian; F Gonzalez-Scarano; J Fantini
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  HIV infection among female partners of seropositive men in Brazil. Rio de Janeiro Heterosexual Study Group.

Authors:  M D Guimarães; A Muñoz; C Boschi-Pinto; E A Castilho
Journal:  Am J Epidemiol       Date:  1995-09-01       Impact factor: 4.897

View more
  43 in total

Review 1.  Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors.

Authors:  B Dunbar; M Patel; J Fahey; C Wira
Journal:  Mol Cell Endocrinol       Date:  2012-01-25       Impact factor: 4.102

2.  HIV binding, penetration, and primary infection in human cervicovaginal tissue.

Authors:  Diane Maher; Xiaoyun Wu; Timothy Schacker; Julie Horbul; Peter Southern
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

3.  Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.

Authors:  Daniel O Ochiel; John V Fahey; Mimi Ghosh; Severina N Haddad; Charles R Wira
Journal:  Curr Womens Health Rev       Date:  2008-05

4.  Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiol.

Authors:  Kimberly D Coleman; Mimi Ghosh; Sarah G Crist; Jacqueline A Wright; Richard M Rossoll; Charles R Wira; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-08-23       Impact factor: 3.886

Review 5.  Innate and adaptive anti-HIV immune responses in the female reproductive tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Charles R Wira
Journal:  J Reprod Immunol       Date:  2013-03       Impact factor: 4.054

Review 6.  Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications.

Authors:  Barbara L Shacklett; Ruth M Greenblatt
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

7.  Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women.

Authors:  Andrea Ries Thurman; Neelima Chandra; Nazita Yousefieh; Irina Zalenskaya; Thomas Kimble; Susana Asin; Christiane Rollenhagen; Sharon M Anderson; Betsy Herold; Pedro M M Mesquita; Nicola Richardson-Harman; Tina Cunningham; Jill L Schwartz; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-10       Impact factor: 2.205

Review 8.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

9.  Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.

Authors:  Alison Wright; Michael E Lamm; Yung T Huang
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

Review 10.  A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.

Authors:  Charles R Wira; John V Fahey
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.